Bisphenol F and aniline-based benzoxazine monomers were selected to fabricate basalt, glass and carbon fiber reinforced polybenzoxazine via vacuum infusion, respectively. The impacts of the type of fiber reinforcement on the resulting material properties of the fiber reinforced polymers (FRPs) were studied. FRPs exhibited a homogenous morphology with completely impregnated fibers and near-zero porosity. Carbon fiber reinforced polybenzoxazine showed the highest specific mechanical properties because of its low density and high modulus and strength. However, regarding the flammability, fire, smoke and toxicity properties, glass and basalt reinforced polybenzoxazine outperformed carbon fiber reinforced polybenzoxazine. This work offers a deeper understanding of how different types of fiber reinforcement affect polybenzoxazine-based FRPs and provides access to FRPs with inherently good fire, smoke and toxicity performance without the need for further flame retardant additives.
Basalt fiber‐reinforced polybenzoxazines (BFRP) were manufactured through vacuum infusion using resorcinol bis (diphenyl phosphate) and poly‐(m‐phenylene methylphosphonate) together with bisphenol‐F and aniline based benzoxazine. Different types and loadings of flame‐retardant additives showed to have catalysis or dilution effects in viscosity measurements. BFRPs show well‐penetrated fibers and near‐zero porosity. Additive addition did not influence tensile properties, while apparent interlaminar shear strength decreased indicating a lower adhesion between fiber and matrix. BFRP's heat and smoke release properties increased, though time to ignition increased and flammability behavior improved by decreasing delamination yielding oxygen indices in between 72 and 91%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.